FOXM1/LncRNA COPD-R regulates pulmonary inflammation in chronic obstructive pulmonary disease induced by biomass-related PM2.5
Related Experiment Videos
Fang He1, Lei Tang2, Xiaoying Zhang2
1School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China; State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Diseases, Guangdong Basic Research Center of Excellence for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, China.
Abstract:
Chronic obstructive pulmonary disease (COPD) is closely associated with biomass fuel (BMF) exposure. Biomass-related PM2.5 (BRPM2.5), a fine particulate component of BMF smoke, may contribute to BMF-associated pulmonary inflammation, but the underlying mechanisms remain unclear. This study investigated the role of the FOXM1/lncRNA COPD-R axis in BRPM2.5-induced pulmonary inflammatory responses. A BMF-induced COPD rat model was established, followed by lung tissue RNA sequencing. Rat L2 cells were treated with lncRNA COPD-R knockdown or overexpression with or without BRPM2.5 exposure. qPCR, FISH, Western blotting, ELISA, ChIP, and dual-luciferase reporter assays were performed to assess lncRNA COPD-R expression, localization, inflammatory responses and transcriptional regulation. After 7 months of BMF exposure in rats, 312 differentially expressed lncRNAs were identified, including 294 upregulated and 18 downregulated transcripts. lncRNA COPD-R expression increased from 0.1505 ± 0.04259 in controls to 1.054 ± 0.2983 in the BMF group (P < 0.01). RNA sequencing of L2 cells following lncRNA COPD-R knockdown revealed enrichment of differentially expressed genes in the IL-17 and other inflammatory signaling pathways. Transcription factor prediction, ChIP and dual-luciferase assays supported FOXM1-mediated transcriptional regulation of lncRNA COPD-R through promoter binding. BRPM2.5 increased lncRNA COPD-R expression, whereas lncRNA COPD-R knockdown reduced BRPM2.5-induced CCL2, IL-17F, MMP-9 and TIMP-1 expression. FOXM1 knockdown or overexpression affected lncRNA COPD-R expression and inflammatory responses, whereas lncRNA COPD-R overexpression rescued these effects following FOXM1 knockdown. Collectively, our findings provide new insights into the mechanisms underlying BRPM2.5-induced pulmonary inflammation and suggest that the FOXM1/lncRNA COPD-R axis may play an important role in this process.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease-I: Introduction